Halozyme Reports First Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Halozyme Reports First Quarter 2015 Financial Results

Halozyme Therapeutics (HALO) Tops Q1 EPS by 1c

May 11, 2015 4:07 PM EDT

Halozyme Therapeutics (NASDAQ: HALO) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $18.7 million versus the consensus estimate of $19.4 million.

Halozyme Therapeutics sees FY2015 revenue of $85-95 million, versus the consensus of $93.3 million.

For earnings... More